Treatment outcome in patients with ocular toxocariasis who were followed up for ≥3 months.

N/A = not applicable.P values were obtained using the Wilcoxon signed-rank test.* Standardization of uveitis nomenclature (SUN) working group's grading scheme, based on the number of inflammatory cells present in a 1×1 mm slit beam of maximal intensity (grade 0: 50 cells).†Recurrence defined as aggravation of ocular inflammation or occurrence of a new granuloma.‡Number of patients showing symptomatic improvement/number of symptomatic patients at baseline.**The data on grade of ocular inflammation at the time of diagnosis and three months after the diagnosis were used.